Immunome (IMNM) Shares Issued (2023 - 2025)
Historic Shares Issued for Immunome (IMNM) over the last 3 years, with Q3 2025 value amounting to $45.5 million.
- Immunome's Shares Issued changed N/A to $45.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $62.2 million, marking a year-over-year decrease of 821.09%. This contributed to the annual value of $20.0 million for FY2024, which is 8400.0% down from last year.
- As of Q3 2025, Immunome's Shares Issued stood at $45.5 million.
- Immunome's Shares Issued's 5-year high stood at $125.0 million during Q2 2023, with a 5-year trough of $34000.0 in Q1 2023.
- Over the past 3 years, Immunome's median Shares Issued value was $9.8 million (recorded in 2024), while the average stood at $31.6 million.
- Over the last 5 years, Immunome's Shares Issued had its largest YoY gain of 997941.18% in 2024, and its largest YoY loss of 9976.0% in 2024.
- Immunome's Shares Issued (Quarter) stood at $64.0 million in 2023, then tumbled by 74.58% to $16.3 million in 2024, then skyrocketed by 179.48% to $45.5 million in 2025.
- Its Shares Issued stands at $45.5 million for Q3 2025, versus $215000.0 for Q2 2025 and $213000.0 for Q1 2025.